MD Anderson Research Highlights for May 4, 2022

Featured studies include clinical advances with a new combination therapy targeting angiogenesis in platinum-resistant ovarian cancer and a promising immunotherapy combination for kidney cancer, plus laboratory studies that focus on targeting ferroptosis in specific lung cancers, developing chimeric antigen receptor (CAR) T cell therapies for blastic plasmacytoid dendritic cell neoplasms, and characterizing racial and ethnic disparities in breast cancer early detection.

The Greatest Gift for Mom: Health and Wellness

Now more than ever, we are reminded that health and wellness should always be a top priority. National Women’s Health Month and Mother’s Day, both celebrated in May, are important reminders that women can take control of their health by making feasible lifestyle choices and focusing on preventive care to lower the risk of certain cancers.

UChicago Medicine, in partnership with Solis Mammography, opens two new breast health centers

Solis Mammography, the nation’s largest independent provider of breast health and diagnostic services, is expanding access to 3D mammography and diagnostic breast health procedures through a partnership with University of Chicago Medicine.

Tackling Breast Cancer with Screening and Prevention

While researchers continue to make advances in breast cancer detection and treatment, one of the best ways to tackle the disease is through early detection and screening. Rutgers Cancer Institute expert shares more about risk factors, warning signs, and screening.

ACR, BCRF and GE Healthcare Announce Trial to Evaluate Use of Contrast Enhanced Mammography for Screening Women with Dense Breasts

In a new effort to improve early breast cancer detection and reduce false positive exams in women with dense breasts, the American College of Radiology, Breast Cancer Research Foundation and GE Healthcare are partnering to support the Contrast Enhanced Mammography Imaging Screening Trial (CMIST).